| Patent application number | Description | Published |
|---|
| 20090248754 | Providing resumption data in a distributed processing system - An approach for providing a user with resumption data before pausing or terminating a partially-processed job that is processing in a distributed system. Certain applications, when paused, are not able to resume processing data at precisely the point where it was paused. As a result, users surrender some, or all, of the processed portion of the data when processing is paused. In one embodiment of the invention, a user is provided with resumption data before the user confirms a request to pause the processing. Resumption data from each of the service nodes that is processing a segment of source data are collected and aggregated. Resumption data reflects a measure of processed data that would require re-processing if the processing were paused and resumed. Alternatively, resumption data includes a duration of spent processing time that would be lost if the processing were paused and resumed. | 10-01-2009 |
| 20090274393 | Automatic image cropping - Upon enabling an automatic cropping feature, a computer-implemented method for cropping a plurality of images retrieves a number of images to process among the plurality of images, and selects an image from the plurality of images to determine a set of crop values for the image until the set of crop values for each image have been determined. Determining a set of crop values for an image includes scanning the image from a first side to an opposing side to determine for each scan line of the image an amount representing a degree of color variation among the pixels for that scan line. The amount determined for each scan line is then compared to a threshold value until a crop value for a first area of the image can be determined. | 11-05-2009 |
| 20100332981 | Providing Media Settings Discovery in a Media Processing Application - Some embodiments provide a method for automatically identifying settings of a media file. The method initially receives the identification of a piece of media content. Media content includes sound and image data that can be stored as a media file. It then performs an automated process for discovering the media settings of the media file. Examples of settings that are automatically identified in some embodiments include video codec type, audio codec type, frame height and frame width, video bit rate, video frame rate, audio channels, etc. The method then stores the media settings that are discovered from the media file. The stored media settings are used subsequently in some embodiments to generate a media file. | 12-30-2010 |
| Patent application number | Description | Published |
|---|
| 20090262419 | Soft aperture correction for lenticular screens - An apparatus including an autostereoscopic image selection device having a plurality of lenticules is provided. The autostereoscopic image selection device has an opaque material applied thereto in gaps between the plurality of lenticules. The opaque material is applied to the autostereoscopic image selection device in a soft aperturing manner, the soft aperturing manner comprising applying the opaque material such that the opaque material is tapered from the gaps over the plurality of lenticules. The opaque material can be applied in accordance with a windowing function. | 10-22-2009 |
| 20100277577 | Enhanced ZScreen modulator techniques - A method and system for use in conjunction with a push-pull liquid crystal modulator system for creating circularly polarized light of alternating handedness is provided. The method and system comprise a pair of surface mode liquid crystal cells and a driver electrically coupled to the cells. The driver is configured to move an electrical charge using a quenching pulse comprising a relatively brief voltage spike at a beginning of a waveform period. Multiple additional improvements are provided, including reducing the thickness of the LC gap (the distance between cell electrode plates), creating a charge connection or wiring connection to the cell electrodes, employing anti-reflection coating technology, thinner ITO and ITO index matched to the LC material, bonding all possible air to material surfaces, using superior glass, employing more efficient polarizers, and reducing projector blanking time. | 11-04-2010 |
| 20110013828 | Stereoscopic format converter - A device and method for converting one stereoscopic format into another. A software-enabled matrix is used to set forth predefined relationships between one type of format as an input image and another type of format as an output image. The matrix can then be used as a look-up table that defines a correspondence between input pixels and output pixels for the desired format conversion. | 01-20-2011 |
| Patent application number | Description | Published |
|---|
| 20090088367 | Treatment of Insulin Resistance/Metabolic Syndrome to Alleviate the Risks of Dementia - This invention relates to Applicant's discovery that Metabolic Syndrome, a cluster of disorders stemming from a resistance to insulin, contributes directly to dementia, particularly Alzheimer's disease. Applicant's invention includes a screening method to determine susceptibility and diagnosis of dementia based on the risk factors for Metabolic Syndrome. Applicant's invention further includes methods for the prevention or treatment of dementia and other neurological conditions based on (1) minimizing insulin resistance, thereby preventing excess biosynthesis of insulin; (2) modulating the activity of IDE such that insulin competes less efficiently with β-amyloid protein for the IDE; and (3) blocking the consequences of NMDA receptor activation, such as by minimizing the generation of NO and other harmful free radicals. | 04-02-2009 |
| 20090093409 | NEUROPROTECTIVE SYNERGY OF ERYTHROPOIETIN AND INSULIN-LIKE GROWTH FACTORS - The present invention provides a method of providing acute neuroprotection by inducing the erythropoietin (EPO) signaling pathway in neuronal cells close to or subsequent to the time of excitatory insult; and inducing an insulin-like growth factor (IGF) signaling pathway in the neuronal cells close to or subsequent to the time of excitatory insult, thereby producing a synergistic acute neuroprotective effect in the neuronal cells. The invention also provides a method of preventing or reducing the severity of a neurologic condition in a subject by administering to the subject EPO or an active fragment or analog thereof at a dose of at most 2000 U/kg; and administering to the subject an IGF or an active fragment or analog thereof, thereby providing neuroprotection and preventing or reducing the severity of the neurologic condition. Such a method can be used to prevent or reduce the severity of, for example, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, amyotrophic lateral sclerosis, multiple sclerosis, a movement disorder, HIV-associated dementia, HIV-associated neuropathy, neuropathic pain, migraine, glaucoma, drug addiction, drug withdrawal, drug dependency, depression or anxiety. | 04-09-2009 |
| 20100137448 | Methods for Treating Neuropsychiatric Disorders with NMDA Receptor Antagonists - The present invention relates to compositions and methods for treating a human patient afflicted with a neuropsychiatric disorder. Specifically, the invention provides for compositions and methods of modulating or antagonizing the activity of neuronal NMDA receptors, wherein such antagonistic activity is capable of modulating the glutamate induced excitatory response of the neurons, thereby inhibiting an excitotoxic effect, promoting a neurotrophic effect, and thereby providing a therapeutic effect that treats the neuropsychiatric disorder. | 06-03-2010 |
| 20110045098 | EXCITATORY GLYCINE RECEPTORS AND METHODS - The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods. | 02-24-2011 |
| 20110212070 | METHODS OF DIFFERENTIATING AND PROTECTING CELLS BY MODULATING THE P38/MEF2 PATHWAY - The present invention provides a method of differentiating progenitor cells to produce a population containing protected neuronal cells. A method of the invention includes the steps of contacting the progenitor cells with a differentiating agent; and introducing into the progenitor cells a nucleic acid molecule encoding a MEF2 polypeptide or an active fragment thereof, thereby differentiating the progenitor cells to produce a population containing protected neuronal cells. In one embodiment, the MEF2 polypeptide is human MEF2C or an active fragment thereof. | 09-01-2011 |
| 20110293556 | TREATMENT OF INSULIN RESISTANCE/METABOLIC SYNDROME TO ALLEVIATE THE RISKS OF DEMENTIA - This invention relates to Applicant's discovery that Metabolic Syndrome , a cluster of disorders stemming from a resistance to insulin, contributes directly to dementia, particularly Alzheimer's disease. Applicant's invention includes a screening method to determine susceptibility and diagnosis of dementia based on the risk factors for Metabolic Syndrome. Applicant's invention further includes methods for the prevention or treatment of dementia and other neurological conditions based on (1) minimizing insulin resistance, thereby preventing excess biosynthesis of insulin; (2) modulating the activity of IDE such that insulin competes less efficiently with β-amyloid protein for the TDE; and (3) blocking the consequences of NMDA receptor activation, such as by minimizing the generation of NO and other harmful free radicals. | 12-01-2011 |
